Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA-Backed Legislation Would Allow for Inflation-Adjusted Fee Schedule Payment

Apr 14, 2023/News

The bill could help reverse the Medicare system's downward payment spiral. Now's the time to voice your support.

APTA, 100-Plus Other Groups to Congress: Fix the 2023 Fee Schedule Now

Dec 6, 2022/News

Groups representing more than a million providers are urging lawmakers to prevent the entire 4.5% cut that will take effect Jan. 1.

Advocates, Leaders Drive Payment Momentum During APTA Payment Advocacy Summit

Jul 27, 2026/Article

The APTA Payment Advocacy Summit brought together 450 physical therapy advocates, business leaders, and payment experts at a critical moment in APTA's fight to advance physical therapy payment policies that support practice sustainability and patient access to care. Building on the momentum of recent

Defining Cash Practice

The term “cash practice” can be confusing because it is often used to describe a variety of physical therapy business models.

Let the Binge-Watching Begin: APTA CSM Content Available Through March 31

Mar 3, 2021/Roundup

The virtual event may be over, but registrants can still load up on great programming. Here are a few suggestions.

Modern Science, Ancient Practice

Jun 1, 2017/Column

Physical therapy and yoga, working together for patients.

Coronavirus Update: May 24

May 24, 2022/Roundup

One million deaths, long COVID in older adults, boosters for children, health care worker burnout, and more.

'You Can't Care if You Aren't There': Provider Mental Health Can't Be Ignored

May 13, 2022/Perspective

Why are so many in the physical therapy community so quick to put everything else above their own personal needs?

Coronavirus Update: March 28

Mar 28, 2022/Roundup

COVID relief money recoupment, telehealth, BA.2 variant, a COVID-19/diabetes relationship, and more.

Coronavirus Update, Sept. 8

Sep 8, 2021/Roundup

CDC guidance for the fully vaccinated, new COVID-19 variant, vaccine effectiveness among the immunocompromised, and more.